Zhengjun Yang, Xin Wang, Ran Meng, Jiayi Han, Qian Li, Xuchen Cao. "A molecular subtype–guided, chemotherapy-free neoadjuvant strategy using SHR-A1811 plus pertuzumab for hormone receptor–positive/HER2-positive breast cancer: A phase II trial in progress.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps653